Clinical Trial Update: A Study of RTP-026 to Assess Safety, Tolerability and Efficacy in Patients With ST-Elevation Myocardial Infarction (STEMI) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for RTP-026 evaluating safety, tolerability, and efficacy in ST-elevation myocardial infarction is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• St-elevation Myocardial Infarction

Drugs mentioned

• RTP-026

Snippet

Sponsor: ResoTher Pharma | Conditions: ST Elevation Myocardial Infarction | Phase 2 | Status: RECRUITING